Stay updated on Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.

Latest updates to the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision note updated from v3.4.1 to v3.4.2; no other page content changes to the study details, eligibility, or locations are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page now displays Revision: v3.4.1 and the prior Revision: v3.4.0 has been removed.SummaryDifference0.0%

- Check32 days agoChange DetectedShow glossary added and page metadata updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older labels such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed or changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe revision tag updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check67 days agoChange DetectedLocations section updated with new sites in California, Florida, Illinois, Maryland, Massachusetts, New York, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Washington, Ontario, and Michigan, and removals from the list (revision 3.3.3 vs 3.3.2).SummaryDifference1%

- Check89 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; no substantive study content was changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.